Nexium IV Gains Indication for GERD in Pediatric Patients

Erosive, but Not Nonerosive, GERD Ups Esophageal CA Risk

April 26, 2012

Patients with gastroesophageal reflux disease with a history of esophagitis are at increased risk for esophageal adenocarcinoma, although the absolute risk is low.

Low Gastroprotective Drug Adherence Ups Upper GI Events

April 17, 2012

For patients taking cyclooxygenase-2 inhibitors (coxibs), low adherence to gastroprotective agents (GPAs) increases the risk of upper gastrointestinal (UGI) complications.

More Gastro Events in Patients With Rheumatoid Arthritis

April 11, 2012

The incidence of upper and lower gastrointestinal (GI) events is higher among patients with rheumatoid arthritis (RA), as is the risk of mortality due to GI events, when compared to individuals without RA.

Smoking Found to Be a Risk Factor for Barrett's Esophagus

April 11, 2012

Cigarette smoking may be a modifiable risk factor for Barrett's esophagus.

New Device Approved for Lingering GERD

March 26, 2012

The LINX Reflux Management System has been approved by the U.S. Food and Drug Administration to treat people with gastroesophageal reflux disease (GERD) who continue to have chronic symptoms, despite taking maximum medication and making recommended lifestyle changes.

MAALOX MAX STR TABS

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Calcium carbonate 1g; wild berry, lemon or wintergreen flavor; contains phenylalanine.

MYLANTA MAXIMUM STRENGTH

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Aluminum hydroxide 400mg, magnesium hydroxide 400mg, simethicone 40mg; per 5mL; liq; cherry, mint, orange creme, and original flavor.

NEXIUM IV

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Esomeprazole (as sodium) 20mg, 40mg; per vial; pwd for IV inj after reconstitution or for infusion after reconstitution and dilution.

Updated: 7/20/2011

PREVACID 24HR

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Lansoprazole 15mg; e-c delayed-release granules in caps.

Updated: 2/2/2010

ROBINUL FORTE

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

Glycopyrrolate 2mg; dye-free tabs.

Gastrointestinal Tract > Hyperacidity, GERD, and ulcers

The management of GERD focuses on the reduction of gastric acidity, increasing lower esophageal sphincter pressure, or enhancing esophageal motility. ...
more »

Treatment Update: PediPirox^™-4 Nail Kit (ciclopirox topical solution, 8%)

April 25, 2012

Update on Melanoma Treatment: SYLATRON™ (peg-interferon alfa-2b) for injection, for subcutaneous use

January 23, 2012

Acute Pain Update: SPRIX^® (ketorolac tromethamine) Nasal Spray 15.75 mg per spray

November 29, 2011

Irritable Bowel Syndrome (IBS) Treatments

February 09, 2012

Irritable Bowel Syndrome (IBS) dosing regimens chart (5-HT3 receptor antagonist, anticholinergic [with or without barbiturates or benzodiazepeines] GI motility enhancer).

Evaluation of Irritable Bowel Syndrome (IBS)

April 09, 2010

Irritable Bowel Syndrome (IBS) evaluation chart based on Manning Criteria and Rome III Diagnostic Criteria.

H. pylori Eradication Options for Peptic Ulcer Disease

October 08, 2009

Helicobacter pylori treatment chart for peptic ulcer disease.

Medications with Significant Anticholinergic Properties

October 01, 2009

Commonly prescribed medications that cause significant anticholinergic effect, plus a list of potential adverse consequences.

Gastroesophageal Reflux Disease Management Chart

January 08, 2009

Gastroesophageal reflex disease (GERD) management algorithm chart.